- Shuster S, Dandruff, seborrhoeic dermatitis and Pityrosporum ovale. Cosmet Toiletries (1988) 103(3): 87-91.
- Goudard M, Regli P, Lubrano N, In vitro antifungal spectrum of Ciclopirox Olamine. Pathol Biol (Paris) (1989) 37: 621-3.
- Jue SG, Dawson GW, Brogden RN, Ciclopirox Olamine 1% Cream. A preliminary review of its antimicrobial activity and therapeutic use. Drugs (1985) 29: 330-41.
- Przekop PA, Lee AA, Bailey SC, et al, Ciclopirox Olamine, an antifungal modulator of neutrophil function and infiltrate in cutaneous inflammation. J Invest Dermatol (1994) 102(4): 583.
- Shuttleworth D, Squire RA, Boorman GC, et al, Comparative clinical efficacy of shampoos containing Ciclopirox Olamine (1.5%) or Ketoconazole (2.0%) shampoo (Nizoral?) for the control of dandruff/seborrhoeic dermatitis. J Dermatol Treat (1998) 9:157-62.
- Vardy DA, Zvulunov A, Tchetov T, et al, A double-blind, placebo-controlled trial of a Ciclopirox Olamine 1% shampoo for the treatment of scalp seborrhoeic dermatitis. J Dermatol Treat (2000) 11: 73-7.
- Faergemann J, Treatment of seborrhoeic dermatitis of the scalp with ketoconazole shampoo. A double-blind study. Acta Derm Venereol (I990) 70(2): 171-2.
- Berger R, Mills OH Jr, Jones EL, Mrusek S, Double-blind placebo-controlled trial of ketoconazole 2% shampoo in the treatment of moderate to severe dandruff. ADV-THER (1990) 7(5): 247-56.
- Peter RU, Richarz-Barthauer U, Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicentre, double-blind, placebo-controlled trial. Br J Dermatol (1995) 132(3): 441-5.
- Futterer E, Evaluation of anti-dandruff agents. J Sac Cosmet Chem (1981) 32: 327-38.
- Rice JA. Mathematical statistics and data analysis, 2nd edn. Duxbury Press; Massachusetts, 1995.
- Wilcoxon F, Individual comparisons by ranking methods. Biometrika Bull (1945) 80-3.
- Mantel N, Haenszel W, Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer hist (1959) 22: 718-48.
A randomised, single-blind, single-centre clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%), or ketoconazole (2%, Nizoral ® ) for the treatment of dandruff/seborrhoeic dermatitis
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.